Quintiliani R, Nightingale C
Clin Orthop Relat Res. 1984 Nov(190):31-5.
New antibiotics must demonstrate an advantage over older agents with respect to therapeutic efficacy, protection against infection, toxicity, cost, and pharmacokinetic properties before they can be approved for public consumption. In order to use antibiotics properly, we must know more about whether certain organisms are resistant or sensitive to the drug; it must also be determined how sensitive or resistant the bacterium is to the drug and how long serum and tissue levels remain above inhibitory or bactericidal concentrations of the drug for the suspected or proven pathogen. Cost issues and potential for adverse reactions must also be considered. In brief, to prevent or treat infections the clinician must be familiar with the microbiology, pharmacology, toxicology, and cost of antibiotics.
新抗生素在获得批准供公众使用之前,必须在治疗效果、抗感染能力、毒性、成本和药代动力学特性等方面展现出相对于旧有药物的优势。为了正确使用抗生素,我们必须更深入了解某些微生物对药物是耐药还是敏感;还必须确定细菌对药物的敏感或耐药程度,以及对于疑似或已证实的病原体,血清和组织水平在多长时间内保持高于药物的抑菌或杀菌浓度。成本问题以及不良反应的可能性也必须加以考虑。简而言之,为了预防或治疗感染,临床医生必须熟悉抗生素的微生物学、药理学、毒理学和成本。